The government of Sao Paulo, the largest state in Brazil, confirmed on Monday two cases of people infected by the new strain of coronavirus, the same that has been putting parts of the UK in lockdown since the end of December.
Brazil's health regulator Anvisa said over the weekend it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.
China’s meat importers and processors have asked exporters in countries with Covid-19 outbreaks to step up disinfection procedures before shipping them to the Asian country.
As people around the world celebrated New Year's Eve 12 months ago, a new global threat emerged. Since that moment, the COVID-19 pandemic has taken so many lives and caused massive disruption to families, societies and economies all over the world.
The World Health Organization (WHO) listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.
From the repatriation of British tourists stranded in Chile to the preparations for the UK’s exit from the EU, Ambassador Ian Duddy, speaks about this year's work.
Argentina's regulator on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, AstraZeneca said in a statement.
Brazil will soon weigh emergency-use approval for AstraZeneca's COVID-19 vaccine after Britain gave the green light on Wednesday, as Latin America's largest country rushes to catch up with immunization programs under way around the hard-hit region.
Brazilian syringe and needle makers warned on Wednesday the country's coronavirus vaccination program was at risk after the government set auction prices too low and failed to draw bids for enough syringes to meet its requirements.
The COVID-19 vaccine developed by British drug maker AstraZeneca Plc and Oxford University will likely be authorized for emergency use in the United States in April, the chief adviser for the U.S. COVID-19 vaccine program said on Wednesday.